Impact of symptom resolution on medication adherence in first episode psychosis

Psychiatry Research

Volumn 196, Issue 1, 2012, Pages 45-51

  Steger, Katherine A ^a   Cassidy, Clifford ^a   Rabinovitch, Mark ^a   Joober, Ridha ^a   Malla, Ashok ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Early intervention; Medication efficacy; Negative symptoms; Non compliance; Positive symptoms

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EARLY INTERVENTION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; REMISSION; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REMISSION INDUCTION; TIME FACTORS;

EID: 84860648847     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.10.015     Document Type: Article

References (48)

1. Addington D., Addington J., Schissel B. A depression rating scale for schizophrenics. Schizophrenia Research 1990, 3(4):247-251.
2. Andreasen N. Scale for Assessment of Negative Symptoms (SANS) 1983, Department of Psychiatry, College of Medicine, The University of Iowa, Iowa City.
3. Andreasen N. Scale for Assessment of Positive Symptoms (SAPS) 1984, Department of Psychiatry, College of Medicine, The University of Iowa, Iowa City.
4. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 2005, 162(3):441-449.
5. Ascher-Svanum H., Faries D.E., Baojin Z.H.U., Ernst F.R., Swartz M.S., Swanson J.W. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry 2006, 67(3):453-460.
6. Ascher-Svanum H., Zhu B., Faries D., Lacro J.P., Dolder C.R. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. Journal of Clinical Psychiatry 2006, 67(7):1114-1123.
7. Barnes T.R. A rating scale for drug-induced akathisia. The British Journal of Psychiatry 1989, 154(5):672-676.
8. Cassidy C.M., Norman R., Manchanda R., Schmitz N., Malla A. Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years. Schizophrenia Bulletin 2010, 36(5):1001-1008.
9. Cassidy C.M., Rabinovitch M., Schmitz N., Joober R., Malla A. A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. Journal of Clinical Psychopharmacology 2010, 30(1):64-67.
10. Chouinard G., Ross-Chouinard A., Annable L., Jones B. Extrapyramidal symptom rating scale. Canadian Journal of Neurological Sciences 1980, 7(3):233.
11. Clatworthy J., Bowskill R., Rank T., Parham R., Horne R. Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients beliefs about the condition and its treatment. Bipolar Disorders 2007, 9(6):656-664.
12. Coldham E.L., Addington J., Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 2002, 106(4):286-290.
13. Corrigan P.W., Salzer M., Ralph R.O., Sangster Y., Keck L. Examining the factor structure of the Recovery Assessment Scale. Schizophrenia Bulletin 2004, 30(4):1035-1041.
14. Favre S., Huguelet M., Vogel S., Gonzalez M. Neuroleptic compliance in a cohort of first episode schizophrenics: a naturalistic study. The European journal of psychiatry 1997, 11(1):35-42.
15. Fenton W.S., Blyler C.R., Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 1997, 23(4):637-651.
16. First M., Spitzer R.I., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders 2002, State Psychiatric Institute, Biometrics Research Department, New York. Patient Edition.
17. Gearing R.E., Charach A. Medication adherence for children and adolescents with first-episode psychosis following hospitalization. European Child & Adolescent Psychiatry 2009, 18(10):587-595.
18. Kamali M., Kelly B., Clarke M., Browne S., Gervin M., Kinsella A., Lane A., Larkin C., O'Callaghan E. A prospective evaluation of adherence to medication in first episode schizophrenia. European Psychiatry 2006, 21(1):29-33.
19. Kampman O., Laippala P., Väänänen J., Koivisto E., Kiviniemi P., Kilkku N., Lehtinen K. Indicators of medication compliance in first-episode psychosis. Psychiatry Research 2002, 110(1):39-48.
20. Karow A., Czekalla J., Dittmann R.W., Schacht A., Wagner T., Lambert M., Schimmelmann B.G., Naber D. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. The Journal of Clinical Psychiatry 2007, 68(1):75-80.
21. Karve S., Cleves M.A., Helm M., Hudson T.J., West D.S., Martin B.C. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Current Medical Research and Opinion 2009, 25(9):2303-2310.
22. Kay S.R., Fiszbein A., Opfer L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13(2):261-276.
23. Kikkert M.J., Schene A.H., Koeter M.W.J., Robson D., Born A., Helm H., Nose M., Goss C., Thornicroft G., Gray R.J. Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophrenia Bulletin 2006, 32(4):786-794.
24. Kinon B.J., Ascher-Svanum H., Adams D.H., Chen L. The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials. Journal of Clinical Psychopharmacology 2008, 28(5):544-549.
25. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 2002, 63(10):892-909.
26. Lambert M., Conus P., Cotton S., Robinson J., McGorry P.D., Schimmelmann B.G. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. Journal of Clinical Psychopharmacology 2010, 30(5):565-572.
27. Law M.R., Soumerai S.B., Ross-Degnan D., Adams A.S. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. The Journal of Clinical Psychiatry 2008, 69(1):47-53.
28. Lecomte T., Spidel A., Leclerc C., MacEwan G.W., Greaves C., Bentall R.P. Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis. Schizophrenia Research 2008, 102(1-3):295-302.
29. Liu-Seifert H., Adams D.H., Kinon B.J. Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Medicine 2005, 3(1):21-30.
30. Malla A., Norman R., McLean T., Scholten D., Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Australian and New Zealand Journal of Psychiatry 2003, 37(4):407-413.
31. Malla A., Norman R., Schmitz N., Manchanda R., BÉChard-Evans L., Takhar J., Haricharan R.A.J. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychological Medicine 2006, 36(05):649-658.
32. Masand P.S., Roca M., Turner M.S., Kane J.M. Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Primary Care Companion to The Journal of Clinical Psychiatry 2009, 11(4):147-154.
33. McEvoy J.P., Johnson J., Perkins D., Lieberman J.A., Hamer R.M., Keefe R.S.E., Tohen M., Glick I.D., Sharma T. Insight in first-episode psychosis. Psychological Medicine 2006, 36(10):1385-1394.
34. Miller B.J. A review of second-generation antipsychotic discontinuation in first-episode psychosis. Journal of Psychiatric Practice 2008, 14(5):289-300.
35. Mojtabai R., Lavelle J., Gibson P.J., Sohler N.L., Craig T.J., Carlson G.A., Bromet E.J. Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Psychiatric Services 2002, 53(3):337-339.
36. Mutsatsa S.H., Joyce E.M., Hutton S.B., Webb E., Gibbins H., Paul S., Barnes T.R.E. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scandinavica 2003, 108(6):439-446.
37. Norman R.M.G., Malla A.K., Verdi M.B., Hassall L.D., Fazekas C. Understanding delay in treatment for first-episode psychosis. Psychological Medicine 2004, 34(02):255-266.
38. Novak-Grubic V., Tavcar R. Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. European Psychiatry 2002, 17(3):148-154.
39. Perkins D., Gu H., Weiden P., McEvoy J., Hamer R., Lieberman J. Comparison of Atypicals in First Episode study group. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. The Journal of Clinical Psychiatry 2008, 69(1):106-113.
40. Perkins D.O., Johnson J.L., Hamer R.M., Zipursky R.B., Keefe R.S., Centorrhino F., Green A.I., Glick I.B., Kahn R.S., Sharma T. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophrenia Research 2006, 83(1):53-63.
41. Quach P.L., Mors O., Christensen T.Ø., Krarup G., Jørgensen P., Bertelsen M., Jeppesen P., Petersen L., Thorup A., Nordentoft M. Predictors of poor adherence to medication among patients with first episode schizophrenia spectrum disorder. Early Intervention in Psychiatry 2009, 3(1):66-74.
42. Robinson D., Woerner M.G., Alvir J.M.J., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 1999, 56(3):241-247.
43. Robinson D.G., Woerner M.G., Alvir J.M.J., Bilder R.M., Hinrichsen G.A., Lieberman J.A. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research 2002, 57(2-3):209-219.
44. Rogers A., Day J.C., Williams B., Randall F., Wood P., Healy D., Bentall R.P. The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Social Science & Medicine 1998, 47(9):1313-1323.
45. San L. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. European Psychiatry 2007, 22(8):490-498.
46. Valenstein M., Copeland L.A., Blow F.C., McCarthy J.F., Zeber J.E., Gillon L., Bingham C.R., Stavenger T. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 2002, 40(8):630-639.
47. Velligan D.I., Weiden P.J., Sajatovic M., Scott J., Carpenter D., Ross R., Docherty J.P. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry 2009, 70(Suppl. 4):1-48.
48. Verdoux H., Lengronne J., Liraud F., Gonzales B., Assens F., Abalan F., van Os J. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatrica Scandinavica 2000, 102:203-210.